Capillary loss and fibrosis in experimental kidney disease is prevented with TIE2 activation

In this episode, Marie Jeansson explains how the paper's findings suggest that TIE2 activation via angiopoietin-2 (ANGPT2)-binding and TIE2-activating antibody warrants investigation as a therapy in human CKD, where there is a substantial unmet medical need.

STING-mediated antitumor immunity and CDK12/13 inactivation triggers

In this episode, Yi Bao explains the that the manuscript's findings establish STING activation as the key driver of T cell infiltration and the immune-hot tumor microenvironment in CDK12 mutant cancers, suggesting that dual CDK12/13 inhibitors and degraders activate anti-tumor immunity and potentiate responses to immunotherapies.

Spesolimab targets IL-36R to alleviate inflammation and reduce generalized pustular psoriasis flares

In this episode, James G. Kreuger explains that people with generalized pustular psoriasis experience underlying skin inflammation, even in the absence of flares. Spesolimab treatment helps control the inflammation and prevent future flares.

Cyclin D1 overexpression causes replication stress and repair pathway dependence

In this episode, Dr. Jithma Prasad Abeykoon, explains how Cyclin D1 overexpression causes DNA damage and forces cancer cells to depend on targetable repair pathways.

Baricitinib rapidly treats lichen planus by suppressing cytotoxic CXCL13+CD8+ T cells.

In this episode, Aaron R. Mangold explains how lichen planus is treated by suppressing cytotoxic CXCL13+CD8+ T-cells using baricitinib.